SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Centocor ( CNTO ) -- Ignore unavailable to you. Want to Upgrade?


To: jopawa who wrote (807)11/5/1998 7:17:00 AM
From: Henry Niman  Respond to of 965
 
The biocognizance.com site is down again. The BBRS and Bear
Stearns reviews of the RA meeting and Enbrel, Remicade, Celebrex, and Vioxx are linked to the New Therapeutics section at
home.att.net



To: jopawa who wrote (807)11/5/1998 4:49:00 PM
From: David S.  Respond to of 965
 
sort of, kind of, not really...xemilofiban should be more of a competitor to both cnto, mrk, corr, etc. Orally available products should be preferred vs. getting poked. (Just ask Bill Clinton)